BIOTRONIK Excellence for Life

BIOTRONIK Home Monitoring was a visionary and pioneering achievement at the time of its market launch, and this December 2025 marks its 25th anniversary! Since its inception in 2000, remote monitoring of implants has become the standard of care, with adoption still accelerating worldwide.

In November 2025, BIOTRONIK brought together more than 120 experts at the third Digital Heart Summit in Berlin, under the scientific leadership of Prof. Gerhard Hindricks from DHZC Berlin, to discuss the future of digitally supported cardiac care. The focus was on AI, remote monitoring, and active patient engagement. An interactive Vision Tour showcased the latest technologies that are increasingly being adopted in clinical practice. The summit provides an annual global platform for exchanging ideas on digitalization in cardiology. The recordings are available online now. 

Solia CSP S is specifically designed for conduction system pacing and intended to simplify implant handling without compromising patient outcomes.

Now available as part of the BIOTRONIK CSP portfolio – for smooth and efficient CSP procedures.

BIOTRONIK and the University of Sydney have signed a Memorandum of Understanding (MoU) to jointly advance digital and connected health innovations through 2028.

The collaboration aims to co-design solutions that address real-world clinical needs and hopes to benefit patients particularly in remote or underserved regions with limited access to care.

Heart disease is the leading cause of death among women worldwide. Yet, women’s heart health is too often overlooked.

This is why it’s time to put female cardiac care in the spotlight. At BIOTRONIK, we are united in advancing female cardiac care. Join us in our campaign to empower, educate, and lead the change for healthier hearts.

BIOTRONIK Neuro’s Prospera spinal cord stimulation (SCS) system treats patients suffering from chronic pain, helping them embrace life again. The system uniquely features:

• RESONANCE™, the first and only multiphase stimulation paradigm
• Embrace One, a truly first-of-its-kind ecosystem that provides automatic, objective, remote daily monitoring

_{Prospera SCS System is approved in the US only and is not available outside of the US.}

_{Note: Embrace One is a support platform intended to help manage a patient’s experience with spinal cord stimulation. It is not intended to be used for medical diagnosis or medical treatment.}